HUS1600052I1 - Terápiás szerek farmakokinetikai paramétereinek modulálása - Google Patents

Terápiás szerek farmakokinetikai paramétereinek modulálása

Info

Publication number
HUS1600052I1
HUS1600052I1 HUS1600052C HUS1600052C HUS1600052I1 HU S1600052 I1 HUS1600052 I1 HU S1600052I1 HU S1600052 C HUS1600052 C HU S1600052C HU S1600052 C HUS1600052 C HU S1600052C HU S1600052 I1 HUS1600052 I1 HU S1600052I1
Authority
HU
Hungary
Prior art keywords
therapeutics
modulators
pharmacokinetic properties
pharmacokinetic
properties
Prior art date
Application number
HUS1600052C
Other languages
English (en)
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46465350&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUS1600052(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of HUS1600052I1 publication Critical patent/HUS1600052I1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUS1600052C 2007-02-23 2016-12-12 Terápiás szerek farmakokinetikai paramétereinek modulálása HUS1600052I1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90322807P 2007-02-23 2007-02-23
EP12167590.4A EP2487162B1 (en) 2007-02-23 2008-02-22 Modulators of pharmacokinetic properties of therapeutics

Publications (1)

Publication Number Publication Date
HUS1600052I1 true HUS1600052I1 (hu) 2017-01-30

Family

ID=46465350

Family Applications (2)

Application Number Title Priority Date Filing Date
HUS1600052C HUS1600052I1 (hu) 2007-02-23 2016-12-12 Terápiás szerek farmakokinetikai paramétereinek modulálása
HUS1600053C HUS1600053I1 (hu) 2007-02-23 2016-12-12 Terápiás szerek farmakokinetikai paramétereinek modulálása

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUS1600053C HUS1600053I1 (hu) 2007-02-23 2016-12-12 Terápiás szerek farmakokinetikai paramétereinek modulálása

Country Status (8)

Country Link
EP (6) EP2487162B1 (hu)
DK (3) DK2487161T4 (hu)
HU (2) HUS1600052I1 (hu)
ME (4) ME02628B (hu)
PL (2) PL2487166T3 (hu)
RS (4) RS55351B2 (hu)
SI (4) SI2487163T1 (hu)
UA (1) UA101312C2 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2860995A1 (en) * 2012-01-12 2013-07-18 Gilead Sciences, Inc. Pharmaceutical compositions and methods for their preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037157A (en) * 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
SI1183026T1 (sl) 1999-06-04 2006-10-31 Abbott Lab Izboljsane farmacevtske spojine, vsebujoce ritonavir
KR101636221B1 (ko) 2006-07-07 2016-07-04 길리애드 사이언시즈, 인코포레이티드 치료제의 약동학 특성의 모듈레이터
LT2487162T (lt) 2007-02-23 2016-11-10 Gilead Sciences, Inc. Terapinių agentų farmakokinetinių savybių moduliatoriai

Also Published As

Publication number Publication date
DK2487161T3 (en) 2016-10-24
EP2487166B1 (en) 2016-07-27
ME02628B (me) 2017-06-20
SI2487163T1 (sl) 2016-12-30
EP2487163B1 (en) 2016-08-17
EP2487162A1 (en) 2012-08-15
HUS1600053I1 (hu) 2017-01-30
RS55459B1 (sr) 2017-04-28
EP2487166A1 (en) 2012-08-15
ME02631B (me) 2017-06-20
UA101312C2 (ru) 2013-03-25
EP2487163A1 (en) 2012-08-15
RS55351B1 (sr) 2017-03-31
ME02680B (me) 2017-06-20
EP2487162B1 (en) 2016-08-17
EP2487167A1 (en) 2012-08-15
DK2487163T3 (en) 2016-10-24
PL2487166T3 (pl) 2017-07-31
RS55195B1 (sr) 2017-01-31
SI2487166T1 (sl) 2017-02-28
RS55351B2 (sr) 2024-09-30
DK2487161T4 (da) 2024-06-24
PL2487163T3 (pl) 2017-04-28
SI2487161T1 (sl) 2016-12-30
RS55280B1 (sr) 2017-03-31
DK2487162T3 (en) 2016-10-24
SI2487161T2 (sl) 2024-07-31
EP2487168A1 (en) 2012-08-15
SI2487162T1 (sl) 2016-12-30
ME02582B (me) 2017-06-20
EP2487164A1 (en) 2012-08-15

Similar Documents

Publication Publication Date Title
HUS2000013I1 (hu) Gyógyszerek farmakokinetikai tulajdonságainak modulátorai
AP2985A (en) Modulators of pharmacokinetic properties of therapeutics
HK1143144A1 (en) Modulators of pharmacokinetic properties of therapeutics
HUS1600053I1 (hu) Terápiás szerek farmakokinetikai paramétereinek modulálása